MannKind Corporation

Approval Confirmed

Afrezza

type 1 and type 2 diabetes

Resolved

39days ago

Approval decision · May 29, 2026

What's at stake A final FDA approval decision on Afrezza for type 1 and type 2 diabetes is expected May 29, 2026.

Primary source · SEC 8-K verified 13h ago

“On May 29, 2026, we announced that the U.S. Food and Drug Administration (FDA) approved Afrezza®(insulin human) Inhalation Powder for use in children and adolescents aged 6 and older living with type 1 and type 2 diabetes.”

Add to calendar Post on X Reddit

Provenance